The Oxford AHSN Accelerator programme was launched in 2019 to offer a unique launchpad for innovators and early-stage companies in the Thames Valley and help get their ideas translated into clinical practice in the NHS. The programme was originally held in person but moved online during the pandemic.
The Accelerator programme has helped over 120 start-up companies build and test robust value propositions and create viable business models, as well as identifying their key stakeholders within the healthcare and life sciences environments.
Delivery partners BioCity/We Are Pioneer Group (WAPG) awarded more than £200,000 of in-kind investment and 12 months of business support to all the winners. Programme participants have also gone on to apply their learning to secure around £2 million in additional funding and create new jobs.
Since the conclusion of the 2021 programme, an Oxford AHSN Accelerator alumni group has been established, providing an ongoing online support community for around 40 innovators who have been through the programme.
The winner of the 2021 Accelerator programme was Oxomics. Dr James Larkin, Oxomics CEO and Co-founder, said: “The accelerator process has been really helpful in shaping and refining my ideas and I’m very grateful to Oxford AHSN and WAPG for their input and support.” Read more about Oxomics’ success in this news story.
There are opportunities for corporate sponsors to support the Accelerator programme – and we are also looking to expand our network of experts who mentor participants through the programme. Find out more in our ‘Oxford AHSN Accelerator: from ideas to impact’ brochure – or click on the image above.